National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 381837

History of Changes from the VAERS Wayback Machine

First Appeared on 4/7/2010

381837
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chest pain, Computerised tomogram normal, Convulsion, Cough, Electroencephalogram normal, Full blood count normal, Gait disturbance, Headache, Joint swelling, Muscular weakness, Myalgia, Nuclear magnetic resonance imaging brain normal, Oedema peripheral, Pain in extremity, Photophobia, Presyncope, Syncope, Stress echocardiogram, Laboratory test normal, Decreased appetite, Metabolic function test, Bronchial hyperreactivity, Oropharyngeal pain, Helicobacter test negative

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 7/31/2010

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chest pain, Computerised tomogram normal, Convulsion, Cough, Electroencephalogram normal, Full blood count normal, Gait disturbance, Headache, Joint swelling, Muscular weakness, Myalgia, Nuclear magnetic resonance imaging brain normal, Oedema peripheral, Pain in extremity, Photophobia, Presyncope, Syncope, Stress echocardiogram, Laboratory test normal, Decreased appetite, Metabolic function test, Bronchial hyperreactivity, Oropharyngeal pain, Helicobacter test negative

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 8/31/2010

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Difficulty in walking, Gait disturbance, Muscular weakness, Myalgia, Oedema peripheral, Pain in extremity, Syncope, Laboratory test normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 1/4/2011

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Difficulty in walking, Gait disturbance, Muscular weakness, Myalgia, Oedema peripheral, Pain in extremity, Syncope, Laboratory test normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 4/13/2011

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chest pain, Computerised tomogram normal, Convulsion, Cough, Electroencephalogram normal, Full blood count normal, Gait disturbance, Headache, Joint swelling, Muscular weakness, Myalgia, Nuclear magnetic resonance imaging brain normal, Oedema peripheral, Pain in extremity, Photophobia, Presyncope, Syncope, Stress echocardiogram, Laboratory test normal, Decreased appetite, Metabolic function test, Bronchial hyperreactivity, Oropharyngeal pain, Helicobacter test negative

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 5/13/2011

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chest pain, Computerised tomogram normal, Convulsion, Cough, Electroencephalogram normal, Full blood count normal, Gait disturbance, Headache, Joint swelling, Muscular weakness, Myalgia, Nuclear magnetic resonance imaging brain normal, Oedema peripheral, Pain in extremity, Photophobia, Presyncope, Syncope, Stress echocardiogram, Laboratory test normal, Decreased appetite, Metabolic function test, Bronchial hyperreactivity, Oropharyngeal pain, Helicobacter test negative

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 6/11/2011

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chest pain, Computerised tomogram normal, Convulsion, Cough, Electroencephalogram normal, Full blood count normal, Gait disturbance, Headache, Joint swelling, Muscular weakness, Myalgia, Nuclear magnetic resonance imaging brain normal, Oedema peripheral, Pain in extremity, Photophobia, Presyncope, Syncope, Stress echocardiogram, Laboratory test normal, Decreased appetite, Metabolic function test, Bronchial hyperreactivity, Oropharyngeal pain, Helicobacter test negative

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 6/14/2014

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chest pain, Computerised tomogram normal, Convulsion, Cough, Electroencephalogram normal, Full blood count normal, Gait disturbance, Headache, Joint swelling, Muscular weakness, Myalgia, Nuclear magnetic resonance imaging brain normal, Oedema peripheral, Pain in extremity, Photophobia, Presyncope, Syncope, Stress echocardiogram, Laboratory test normal, Decreased appetite, Metabolic function test, Bronchial hyperreactivity, Oropharyngeal pain, Helicobacter test negative

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 3/14/2015

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Arthralgia, Chest pain, Computerised tomogram normal, Convulsion, Cough, Electroencephalogram normal, Full blood count normal, Gait disturbance, Headache, Joint swelling, Muscular weakness, Myalgia, Nuclear magnetic resonance imaging brain normal, Oedema peripheral, Pain in extremity, Photophobia, Presyncope, Syncope, Stress echocardiogram, Laboratory test normal, Decreased appetite, Metabolic function test, Bronchial hyperreactivity, Oropharyngeal pain, Helicobacter test negative

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 2/14/2017

381837 Before After
VAERS Form:
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Gait disturbance, Muscular weakness, Myalgia, Oedema peripheral, Pain in extremity, Syncope, Laboratory test normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


Changed on 9/14/2017

381837 Before After
VAERS Form:(blank) 1
Age:14.0
Gender:Female
Location:Texas
Vaccinated:2007-11-26
Onset:2008-08-01
Submitted:2010-03-03
Entered:2010-03-04
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. 0263U / 0 1 LA / IM

Administered by: Other      Purchased by: Other
Symptoms: Gait disturbance, Muscular weakness, Myalgia, Oedema peripheral, Pain in extremity, Syncope, Laboratory test normal

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? Yes
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol; PREVACID; SINGULAIR
Current Illness: Asthma; Bronchitis
Preexisting Conditions: Gastrointestinal pain; Gastrooesophageal reflux
Allergies:
Diagnostic Lab Data: diagnostic laboratory, negative
CDC 'Split Type': WAES1002USA03728

Write-up:Information has been received from an office Manager concerning a 15 year old female with asthma and bronchitis, and a history of upper gastrointestinal pain and reflux, and no known allergies, who on 26-NOV-2007 was vaccinated with the first standard dose of GARDASIL, IM. The vaccination dates of the second dose and the third dose were not reported. Concomitant therapy included montelukast sodium, albuterol and PREVACID. In August 2008, after completing the GARDASIL series the patient experienced general muscle weakness, muscle pain, leg pain, leg swelling and syncope. The patient had difficulty walking due to the leg swelling. She sought medical attention via office visit. The patient was hospitalized, but reporter did not know how long the patient was hospitalized. Lab and Diagnostic Studies were done but the Office worker did not know exactly what studies were completed. Patient was seen by Cardiology and Neurology Specialist for intervention to to prevent serious criteria and all findings so far were negative. It was reported that the patient was still following up with various physicians and did not know if the symptoms had resolved at this time. General muscle weakness, muscle pain, leg pain, leg swelling, syncope and difficulty walking were considered to be other important medical events. Leg swelling and difficulty walking were considered to be disabling by the reporter, since the patient had difficulty walking due to the leg swelling. Additional information has been requested.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=381837&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166